Testing the Addition of Cemiplimab to Palbociclib for the Treatment of Advanced Dedifferentiated Liposarcoma

Clinical trial NCT05694871 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05694871
Sponsor: Alliance for Clinical Trials in Oncology
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Dedifferentiated Liposarcoma Locally Advanced Dedifferentiated Liposarcoma Metastatic Dedifferentiated Liposarcoma Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 Stage IV Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 Unresectable Dedifferentiated Liposarcoma

Start date: 2023-06-07
Primary completion: 2027-05-31
Enrollment: 77

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.